EdgeMarketInstruments › VIVS

VIVS — VivoSim Labs, INC.

US Healthcare Pharma & biotech equity mkt cap 999.3K
0.29 +3.06% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 0.28 · high 4.78

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day+3.06%
1 week-11.32%
1 month-36.44%
3 months-78.66%
6 months-85.84%
Year to date-84.79%
1 year-84.37%
3 years-98.38%
5 years-99.69%

Technicals

RSI 1444.0
vs 50-day avg-57.57%
vs 200-day avg-81.41%
Volatility 1y136.6%
Max drawdown 1y-94.20%
Avg volume 30d11.6M
Daily bars held2,674
History from2016-01-04

Measured signals that fired on VIVS

datesignal measured base rate
2026-08-06Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group
2026-04-01Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-01-27Gobel David
Director
Grant or award15.0K0.000
2026-01-27STERN ADAM K
Director
Grant or award15.0K0.000
2026-01-27Milhous Alison Tjosvold
Director
Grant or award15.0K0.000
2026-01-27Cohen Douglas Jay
Director
Grant or award15.0K0.000
2026-01-27Murphy Keith
EXECUTIVE CHAIRMAN
Grant or award15.0K0.000
2025-11-17Gobel David
Director
Open-market sale3.3K2.247.3K
2024-08-07Cohen Douglas Jay
Director
Grant or award19.6K0.000
2024-08-07Joshi Vaidehi
Director
Grant or award19.6K0.000
2024-08-07STERN ADAM K
Director
Grant or award19.6K0.000
2024-08-07Milhous Alison Tjosvold
Director
Grant or award19.6K0.000

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
GEODE CAPITAL MANAGEMENT, LLC52.7K36.9K
GOLDMAN SACHS GROUP INC23.0K16.1K
VANGUARD CAPITAL MANAGEMENT LLC22.0K15.4K
BlackRock, Inc.16.9K11.8K
VANGUARD FIDUCIARY TRUST CO10.0K7.0K
CITIGROUP INC9.3K6.5K
Tower Research Capital LLC (TRC)3.3K2.3K
UBS Group AG1.4K952
SBI Securities Co., Ltd.316221
Allworth Financial LP298208

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d39.6% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about VIVS

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open VIVS in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →